Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7422)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2016 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Calcagno DQ, Takeno SS, Gigek CO, Leal MF, Wisnieski F, Chen ES, Araújo TMT, Lima EM, Melaragno MI, Demachki S, Assumpção PP, Burbano RR, Smith MC. Identification of IL11RA and MELK amplification in gastric cancer by comprehensive genomic profiling of gastric cancer cell lines. World J Gastroenterol 2016; 22(43): 9506-9514 [PMID: 27920471 DOI: 10.3748/wjg.v22.i43.9506] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i43/9506.htm |
| Number | Citing Articles |
| 1 |
Zhen‐Guo Zhang, Hong‐Mei Zhu, Huai‐Kang Hua. Inhibiting IL11RA to mitigate hepatic metastasis in skin cutaneous melanoma: Comprehensive insights from in vitro and in vivo investigations. Skin Research and Technology 2024; 30(3) doi: 10.1111/srt.13618
|
| 2 |
Pengfei Su, Tian Yu, Yingjing Zhang, Hongyun Huang, Moxi Chen, Can Cao, Weiming Kang, Yuqin Liu, Jianchun Yu. Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03453-8
|
| 3 |
Pengfei Su, Qiliang Lu, Yuanyu Wang, Yiping Mou, Weiwei Jin. Targeting MELK in tumor cells and tumor microenvironment: from function and mechanism to therapeutic application. Clinical and Translational Oncology 2024; doi: 10.1007/s12094-024-03664-5
|
| 4 |
Antonio Cigliano, Maria Giulia Pilo, Marta Mela, Silvia Ribback, Frank Dombrowski, Giovanni Mario Pes, Antonio Cossu, Matthias Evert, Diego Francesco Calvisi, Kirsten Utpatel. Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma. Medicina 2019; 56(1): 1 doi: 10.3390/medicina56010001
|
| 5 |
Yimin Zhu, Hanlin Lu, Dandan Zhang, Meiyan Li, Xiaohui Sun, Ledong Wan, Dan Yu, Yiping Tian, Hongchuan Jin, Aifen Lin, Fei Gao, Maode Lai. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer. Clinical Epigenetics 2018; 10(1) doi: 10.1186/s13148-018-0458-3
|
| 6 |
Jiun Kang. Frequent Loss of Chromosome 4q, Homozygous FSTL5 Deletion at the 4q32.2 in Gastric Adenocarcinoma. International Journal of Cancer Research 2017; 14(1): 13 doi: 10.3923/ijcr.2018.13.20
|
| 7 |
Carolina Oliveira Gigek, Danielle Queiroz Calcagno, Lucas Trevizani Rasmussen, Leonardo Caires Santos, Mariana Ferreira Leal, Fernanda Wisnieski, Rommel Rodriguez Burbano, Laercio Gomes Lourenço, Gaspar Jesus Lopes-Filho, Marilia Arruda Cardoso Smith. Genetic variants in gastric cancer: Risks and clinical implications. Experimental and Molecular Pathology 2017; 103(1): 101 doi: 10.1016/j.yexmp.2017.07.004
|
| 8 |
Tingna Chen, Chaogang Yang, Rongzhang Dou, Bin Xiong. Identification of a novel 10 immune‐related genes signature as a prognostic biomarker panel for gastric cancer. Cancer Medicine 2021; 10(18): 6546 doi: 10.1002/cam4.4180
|
| 9 |
Bu-Fu Tang, Ruo-Chen Yan, Si-Wei Wang, Zhao-Chong Zeng, Shi-Suo Du. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity. Cancer Letters 2023; 560: 216126 doi: 10.1016/j.canlet.2023.216126
|
| 10 |
Sara Franceschi, Laura Spugnesi, Paolo Aretini, Francesca Lessi, Rosa Scarpitta, Alvaro Galli, Caterina Congregati, Maria Adelaide Caligo, Chiara Maria Mazzanti. Whole-exome analysis of a Li–Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile. Carcinogenesis 2017; 38(9): 938 doi: 10.1093/carcin/bgx069
|
| 11 |
Ali Mohamed Alshabi, Basavaraj Vastrad, Ibrahim Ahmed Shaikh, Chanabasayya Vastrad. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis. Biomolecules 2019; 9(5): 201 doi: 10.3390/biom9050201
|
| 12 |
Lakshmi Reddy Bollu, Jonathan Shepherd, Dekuang Zhao, Yanxia Ma, William Tahaney, Corey Speers, Abhijit Mazumdar, Gordon B. Mills, Powel H. Brown. Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1. npj Breast Cancer 2020; 6(1) doi: 10.1038/s41523-019-0143-5
|
| 13 |
Laura F. Dagley, Jumana Yousef, Adele Preaudet, Andrea Loving, Andrew I. Webb, Matthias Ernst, Tracy L. Putoczki. Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer. International Journal of Molecular Sciences 2024; 25(6): 3129 doi: 10.3390/ijms25063129
|
| 14 |
Zhi-jian Ren, Yang Zhao, Guan Wang, Le-le Miao, Zheng-chao Zhang, Long Ma, Mu-zhou Teng, Yu-min Li. Identification of differentially expressed miRNAs derived from serum exosomes associated with gastric cancer by microarray analysis. Clinica Chimica Acta 2022; 531: 25 doi: 10.1016/j.cca.2022.03.010
|